Kalaris Therapeutics (KLRS) Misses Q2 EPS by 61c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: KLRS) | Delayed: 2.13 +0.12 (5.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $ | |||
| Open | $2.05 | 52 Week Low | $ | |||
| Day High | $2.16 | P/E | N/A | |||
| Day Low | $2.05 | EPS | $ | |||
| Volume | 23,166 | |||||
